Literature DB >> 9128794

Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection.

M Olmer1, D Bouchouareb, C Zandotti, P de Micco, X de Lamballerie.   

Abstract

Hepatitis C virus (HCV) infection is a frequent feature in hemodialysis (HD) patients. The way of viral transmission is difficult to establish, but in previous studies the role of blood transfusions and of HD treatment duration, and the possibility of nosocomial transmission of the virus have been suggested. We present here the results of a virological follow-up of HCV infection in our HD unit in 1993-1994, and a molecular study of viral strains that led to a possible reconstruction of viral spreading. All patients in our unit were regularly tested for alanine aminotransferase, HCV antibodies and HCV RNA in serum. Seven seroconversions were detected during follow-up, and a high proportion of type 1b HCV strains was found in infected patients. Nucleotide sequences located in the envelope 1 (E1) viral coding region of type 1b strains were compared in our patients and numerous controls infected with the same HCV genotype. A high proportion of patients with antibodies to HCV were detected in our unit (32.5%). Blood transfusions and duration of HD treatment were risk factors for HCV infection. Seroconversions in patients never transfused and predominance of type 1b HCV strains suggested that infection had occurred via the nosocomial pathway in our unit. Similar sequences in the E1 region were found in four patients treated, forming a distinct cluster in a phylogenetic tree. Of these four patients, two had been infected before 1991, and the others made a seroconversion for HCV at the same period in 1994. In all other patients, including a nurse who had been in charge of some infected patients, distinct strains were found. Duration of HD treatment seems to be a major factor of risk for HCF infection in HD units. Contamination could occur during blood transfusion or via the nosocomial pathway through a crossinfection mechanism from patients already infected. The latter mechanism was formally demonstrated in this study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128794

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis units.

Authors:  M Mizuno; T Higuchi; K Kanmatsuse; M Esumi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.

Authors:  Bhadran Bose; Stephen P McDonald; Carmel M Hawley; Fiona G Brown; Sunil V Badve; Kathryn J Wiggins; Kym M Bannister; Neil Boudville; Philip Clayton; David W Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

3.  A shield against a monster: Hepatitis C in hemodialysis patients.

Authors:  Seyed-Moayed Alavian
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

4.  Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.

Authors:  S Le Pogam; D Le Chapois; R Christen; F Dubois; F Barin; A Goudeau
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran.

Authors:  Ali Kargar Kheirabad; Fahime Bahri; Mohammad Kargar; Iman Ghasemzadeh
Journal:  Hepat Mon       Date:  2016-08-13       Impact factor: 0.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.